NO20055602D0 - 4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepin-derivat og salt derav - Google Patents

4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepin-derivat og salt derav

Info

Publication number
NO20055602D0
NO20055602D0 NO20055602A NO20055602A NO20055602D0 NO 20055602 D0 NO20055602 D0 NO 20055602D0 NO 20055602 A NO20055602 A NO 20055602A NO 20055602 A NO20055602 A NO 20055602A NO 20055602 D0 NO20055602 D0 NO 20055602D0
Authority
NO
Norway
Prior art keywords
difluoro
tetrahydro
salt
benzazepine derivative
benzazepine
Prior art date
Application number
NO20055602A
Other languages
English (en)
Other versions
NO333505B1 (no
NO20055602L (no
Inventor
Hiroyuki Koshio
Issei Tsukamoto
Akio Kakefuda
Seijiro Akamatsu
Chikashi Saitoh
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of NO20055602D0 publication Critical patent/NO20055602D0/no
Publication of NO20055602L publication Critical patent/NO20055602L/no
Publication of NO333505B1 publication Critical patent/NO333505B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16Benzazepines; Hydrogenated benzazepines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20055602A 2003-04-28 2005-11-25 4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepinderivat eller salt derav, og anvendelse derav for fremstilling av et medikament NO333505B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003123032 2003-04-28
JP2003401126 2003-12-01
PCT/JP2004/005998 WO2004096775A1 (ja) 2003-04-28 2004-04-26 4,4-ジフルオロ-1,2,3,4-テトラヒドロ-5h-1-ベンゾアゼピン誘導体又はその塩

Publications (3)

Publication Number Publication Date
NO20055602D0 true NO20055602D0 (no) 2005-11-25
NO20055602L NO20055602L (no) 2006-01-24
NO333505B1 NO333505B1 (no) 2013-06-24

Family

ID=33422056

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055602A NO333505B1 (no) 2003-04-28 2005-11-25 4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepinderivat eller salt derav, og anvendelse derav for fremstilling av et medikament

Country Status (17)

Country Link
US (2) US7183271B2 (no)
EP (1) EP1619185B1 (no)
KR (1) KR100882154B1 (no)
AT (1) ATE512951T1 (no)
AU (1) AU2004234258B2 (no)
BR (1) BRPI0409718A (no)
CA (1) CA2521492C (no)
DK (1) DK1619185T3 (no)
IL (1) IL171332A (no)
MX (1) MXPA05011521A (no)
NO (1) NO333505B1 (no)
NZ (1) NZ542815A (no)
PL (1) PL1619185T3 (no)
PT (1) PT1619185E (no)
RU (1) RU2326868C2 (no)
SI (1) SI1619185T1 (no)
WO (1) WO2004096775A1 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
MXPA05011521A (es) 2003-04-28 2006-01-23 Astellas Pharma Inc Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o una sal del mismo.
NZ565080A (en) 2005-07-22 2011-03-31 Mochida Pharm Co Ltd Novel heterocyclidene acetamide derivative
CN101801452B (zh) 2007-08-06 2014-10-22 阿勒根公司 用于去氨加压素药物给送的设备
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
SI3225249T1 (sl) * 2008-05-21 2019-02-28 Ferring B.V. Orodisperzibilen dezmopresin za povečanje začetnega obdobja spanja, ki ga ne moti nokturija
SI2860175T1 (en) 2012-06-11 2018-04-30 Tacurion METHOD FOR MANUFACTURE OF 4,4,7-TRIFLUORO-1,2,3,4-TETRAHYDRO-5H-1-BENZAZEPIN COMPOSITION AND INTERMEDIATE FOR ITS SYNTHESIS
US10906888B2 (en) 2016-07-14 2021-02-02 Pfizer Inc. Pyrimidine carboxamides as inhibitors of Vanin-1 enzyme

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2137760C1 (ru) 1993-08-26 1999-09-20 Яманоути Фармасьютикал Ко., Лтд. Производное бензазепина, фармацевтическая композиция, производное дифторбензазепина и производное (замещенного) аминобензоилдифторбензазепина
ATE360617T1 (de) 1994-06-15 2007-05-15 Otsuka Pharma Co Ltd Benzoheterocyclische verbindungen verwendbar als vasopressin- oder oxytocin-modulatoren
JP3215910B2 (ja) * 1994-06-15 2001-10-09 大塚製薬株式会社 ベンゾヘテロ環誘導体
JPH11349570A (ja) 1994-06-15 1999-12-21 Otsuka Pharmaceut Co Ltd ベンゾヘテロ環誘導体
TW359669B (en) 1995-12-15 1999-06-01 Otsuka Pharma Co Ltd Benzazepine derivatives
JPH09221476A (ja) * 1995-12-15 1997-08-26 Otsuka Pharmaceut Co Ltd 医薬組成物
JPH09221475A (ja) 1996-02-13 1997-08-26 Yamanouchi Pharmaceut Co Ltd 新規なオキシム誘導体
AR011913A1 (es) 1997-03-06 2000-09-13 Yamano Masaki Derivados de 4,4-difluoro-2,3,4,5-tetrahidro-1h-1-benzoazepina y composiciones farmaceuticas de los mismos.
JP2926335B2 (ja) 1997-06-13 1999-07-28 大塚製薬株式会社 医薬組成物
HUP0002480A3 (en) 1997-07-30 2002-09-30 Wyeth Corp Pyrrolo[2,1-c][1,4]benzodiazepine derivatives, their use, process for their preparation and pharmaceutical compositions containing them
NZ502448A (en) 1997-07-30 2002-12-20 Wyeth Corp Tricyclic vasopressin agonists and medicaments containing these compounds
US6547395B1 (en) 1998-02-06 2003-04-15 Wavefront Sciences, Inc. Methods of measuring moving objects and reducing exposure during wavefront measurements
CA2358894A1 (en) 1999-02-04 2000-08-10 American Home Products Corporation Tricyclic pyridine n-oxides vasopressin agonists
GB0000079D0 (en) 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
KR100632882B1 (ko) 2001-11-16 2006-10-13 아스텔라스세이야쿠 가부시키가이샤 4, 4-디플루오로-1, 2, 3,4-테트라하이드로-5h-1-벤즈아제핀 유도체 또는 그 염
MXPA05011521A (es) 2003-04-28 2006-01-23 Astellas Pharma Inc Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o una sal del mismo.

Also Published As

Publication number Publication date
KR20060007402A (ko) 2006-01-24
US7807664B2 (en) 2010-10-05
IL171332A (en) 2011-03-31
NO333505B1 (no) 2013-06-24
US20060122170A1 (en) 2006-06-08
RU2326868C2 (ru) 2008-06-20
WO2004096775A1 (ja) 2004-11-11
EP1619185A4 (en) 2008-07-23
NO20055602L (no) 2006-01-24
US7183271B2 (en) 2007-02-27
CA2521492A1 (en) 2004-11-11
AU2004234258B2 (en) 2009-04-09
CA2521492C (en) 2010-09-21
RU2005136863A (ru) 2006-04-20
PT1619185E (pt) 2011-08-25
NZ542815A (en) 2009-01-31
ATE512951T1 (de) 2011-07-15
EP1619185A1 (en) 2006-01-25
AU2004234258A1 (en) 2004-11-11
PL1619185T3 (pl) 2011-12-30
US20070167429A1 (en) 2007-07-19
KR100882154B1 (ko) 2009-02-06
EP1619185B1 (en) 2011-06-15
BRPI0409718A (pt) 2006-05-02
DK1619185T3 (da) 2011-07-18
MXPA05011521A (es) 2006-01-23
SI1619185T1 (sl) 2011-09-30

Similar Documents

Publication Publication Date Title
NO20055602D0 (no) 4,4-difluor-1,2,3,4-tetrahydro-5H-1-benzazepin-derivat og salt derav
GB0318447D0 (en) Therapeutic agents
CY1113054T1 (el) Παραγωγα διαμινης
ATE283253T1 (de) Substituierte aminopropoxyarylderivate als lxr agonisten
HK1155146A1 (zh) 作為藥物活性劑的茚衍生物
MXPA05012268A (es) N-arilsulfonilpiperidinas enlazadas como inhibidores de la gamma-secretasa.
GB9801690D0 (en) Therapeutic agents
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
EP1591120A4 (en) RECEPTOR AGONISTS
GB0318343D0 (en) No title
MXPA05012323A (es) Sulfonamidas ciclicas para la inhibicion de gama-secretasa.
BR0314688A (pt) Novos derivados de piperidina para utilização no tratamento de estados de doença mediados pela quimiocina
DK1767535T3 (da) Syntese af epothiloner, mellemprodukter deraf, analoge og deres anvendelse
DE602005011113D1 (de) Morphinanderivate als mittel gegen juckreiz
HK1076816A1 (no)
DK1222922T3 (da) Fremgangsmåde til stabilisering af benzimidazolforbindelser
ATE303384T1 (de) 1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
ATE432935T1 (de) N-(1,2,4-triazoloazinyl)thiophensulfonamid- verbindungen als herbizide
SI1578741T1 (sl) Aromatske spojine kot protivnetna imunomodulatorna in antiproliferativna sredstva
IL158965A0 (en) Oxazin (thi) one compounds used as fungicides
TW200603800A (en) 4-arylmorpholin-3-one derivatives, preparation thereof and therapeutic application thereof
ITVI20020004A1 (it) Spaccatrice per pelli
DE60214397D1 (en) 2-(aminomethyl)-tetrahydro-9-oxa-1,3-diaza-cyclopenta(a)naphthalenyl derivate mit antipsychotischer aktivität
DE60214558D1 (de) 2-(AMINOMETHYL)TETRAHYDRO-9-OXA-1,3-DIAZACYCLOPENTAcAÜNAPHTHALINYLDERIVATE MIT ANTIPSYCHOTISCHER WIRKUNG
HU0300710D0 (en) 'fortacs' (kitchen-aid)

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees